NuVasive Announces First Patient in the United States Treated With the PCM Cervical Disc Following FDA Approval
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced that Paul Sawin, M.D., performed the first PCM Cervical Disc surgery on a patient in Orlando, Florida, today. Surgeon proctors, who will instruct upcoming training courses, have started scheduling surgeries now that the new device is available. Surgeon demand for training is strong with courses scheduled to begin next month.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.